Health Information Portal (HIP)

Search
0 results

No results, please enter a search term above

HAI/AR Surveillance Data Reports

The Philadelphia Department of Public Health (PDPH) HAI/AR Program conducts year-round surveillance for multiple drug-resistant organisms of public health concern by collecting clinical and laboratory information from healthcare facilities. The HAI/AR Program also monitors and tracks numerous healthcare-associated infections and metrics that are reported into the Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN), the nation’s most widely used healthcare-associated infections tracking system.

Posting of this data is intended for the purpose of promoting the health of Philadelphia residents and for providing a reference to healthcare providers citywide to inform practice in their own institutions. PDPH attempts to post timely and reliable information, but due to the limitations of the surveillance systems used to generate these data, we cannot guarantee that all data is complete or up-to-date.

Quarter 3: April - June 2024

Carbapenemase-Producing (CP) Status of Confirmed Cases: April - June 2024

Carbapenemase-Producing (CP) Status of Confirmed Cases

Cases, n (%)

CP-CRE

29 (46%)

Non-CP CRE

17 (27%)

CP Status Pending / Not Tested

17 (27%)

Total Confirmed CRE Cases

63

Quarter 2: January - March 2024

Carbapenemase-Producing (CP) Status of Confirmed Cases: January - March 2024

Carbapenemase-Producing (CP) Status of Confirmed Cases

Cases, n (%)

CP-CRE

47 (59%)

Non-CP CRE

17 (22%)

CP Status Pending / Not Tested

15 (19%)

Total Confirmed CRE Cases

79

Quarter 1: October - December 2023

Carbapenemase-Producing (CP) Status of Confirmed Cases: October - December 2023

Carbapenemase-Producing (CP) Status of Confirmed Cases

Cases, n (%)

CP-CRE

42 (59%)

Non-CP CRE

11 (16%)

CP Status Pending / Not Tested

18 (25%)

Total Confirmed CRE Cases

71